Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 09    symbols : SRNE    save search
Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer
Published: 2021-02-09 (Crawled : 14:04) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K twitter stocktwits trandingview |
Health Technology
 | | O: 0.73% H: 3.43% C: -3.07%
china therapy cancer treatment antibody license breakthrough therapy designation
Gainers vs Losers
59% 41%

Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M twitter stocktwits trandingview |
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M twitter stocktwits trandingview |
n/a
GDHG | $0.263 21.76% 25.34% 1.3M twitter stocktwits trandingview |

HOLO | $2.95 31.7% 22.49% 37M twitter stocktwits trandingview |

UMAC | $1.55 0.65% 16.13% 3K twitter stocktwits trandingview |

MTNB | $0.19 -1.04% 14.58% 950K twitter stocktwits trandingview |
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M twitter stocktwits trandingview |
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K twitter stocktwits trandingview |
n/a
MGLD 4 | $1.13 5.61% 10.62% 200 twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.